rcca-header
Clinical Trials

Phase 3, Open-Label Study to Characerize the Incidence and Severity of Diarrhea in Patients with Early stage HER2+ Breast Cancer Treated with Neratinib and Intensive Loperamide Prophylaxis

Type of Cancer
Breast Oncology
Phase
Division (Location)
Howell, NJ, Little Silver, NJ
Study ID
NCT#
Brief Description
Phase 3, Open-Label Study to Characerize the Incidence and Severity of Diarrhea in Patients with Early stage HER2+ Breast Cancer Treated with Neratinib and Intensive Loperamide Prophylaxis

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.